CWS
Confluence Wealth Services’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $498K | Sell |
4,491
-586
| -12% | -$65K | 0.03% | 243 |
|
2025
Q1 | $540K | Sell |
5,077
-387
| -7% | -$41.2K | 0.03% | 223 |
|
2024
Q4 | $508K | Sell |
5,464
-8,871
| -62% | -$824K | 0.03% | 217 |
|
2024
Q3 | $1.2M | Sell |
14,335
-572
| -4% | -$48K | 0.09% | 122 |
|
2024
Q2 | $1.02M | Buy |
14,907
+4,210
| +39% | +$289K | 0.08% | 142 |
|
2024
Q1 | $784K | Buy |
10,697
+2,500
| +30% | +$183K | 0.07% | 160 |
|
2023
Q4 | $664K | Buy |
8,197
+1,179
| +17% | +$95.5K | 0.07% | 157 |
|
2023
Q3 | $526K | Buy |
7,018
+1,247
| +22% | +$93.4K | 0.1% | 152 |
|
2023
Q2 | $445K | Buy |
5,771
+2,177
| +61% | +$168K | 0.09% | 167 |
|
2023
Q1 | $298K | Buy |
+3,594
| New | +$298K | 0.07% | 194 |
|
2022
Q1 | – | Sell |
-284
| Closed | -$20K | – | 594 |
|
2021
Q4 | $20K | Buy |
+284
| New | +$20K | 0.01% | 727 |
|